Chief Medical Officer of Pacira BioSciences, Jonathan Slonin, sold 5,012 shares of the company, now owning 98,869.475 shares. The company focuses on non-opioid products for post-surgical pain management.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing